BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2019
View Archived Issues
CD47 prevents gene therapy from being eaten
Read More
Gallbladder cancer murine models developed from organoid cell lines
Read More
Circulating elafin as potential new biomarker of prediabetic condition
Read More
Urinary Cyr61 and TFF3 as promising new biomarkers in patients with colorectal cancer
Read More
Akero Therapeutics initiates phase IIa study of AKR-001 for the treatment of NASH
Read More
Expansion Therapeutics initiates phase I trial of ERX-963 in adults with DM1
Read More
Polyphor, University of Zurich awarded grant to develop new class of LPS-inhibiting antibiotics
Read More
SNX29 variation plays a role in vasodilator therapy response in PAH
Read More
Strep genome research expedites vaccine development
Read More
TRPV1 as a novel target in gastric cancer therapy
Read More
Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD
Read More
Medshine Discovery divulges mTORC1 and mTORC2 inhibitors
Read More
Sumitomo Dainippon Pharma patents TLR7 antagonists
Read More
Xeomin approved in E.U. for treatment of chronic sialorrhea in adults
Read More
German researchers present new adenosine A2A receptor ligands
Read More
Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH
Read More
Jubilant Biosys describes PD-1/PD-L1 interaction inhibitors
Read More
Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint
Read More
Merck & Co. discovers IDO1 inhibitors
Read More
Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development
Read More
NRF2 gene polymorphism tied to emphysema development in smokers
Read More
Amicus and University of Pennsylvania expand gene therapy collaboration
Read More
AdCh3NSmut1/MVA-NSmut did not protect against HCV infection in phase I/II trial
Read More
Mereo reports 6-month open-label data from phase IIb study of BPS-804 in osteogenesis imperfecta
Read More
Phase III QUARTZ study of QMF-149 in inadequately controlled asthma meets primary endpoint
Read More